A Novel Three-Colour Fluorescence in Situ Hybridization Approach for the Detection of t(7;12)(q36;p13) in Acute Myeloid Leukaemia Reveals New Cryptic Three Way Translocation t(7;12;16)
The t(7;12)(q36;p13) translocation is a recurrent chromosome abnormality that involves the ETV6 gene on chromosome 12 and has been identified in 20–30% of infant patients with acute myeloid leukaemia (AML). The detection of t(7;12) rearrangements relies on the use of fluorescence in situ hybridization (FISH) because this translocation is hardly visible by chromosome banding methods. Furthermore, a fusion transcript HLXB9-ETV6 is found in approximately 50% of t(7;12) cases, making the reverse transcription PCR approach not an ideal screening method. Considering the report of few cases of variant translocations harbouring a cryptic t(7;12) rearrangement, we believe that the actual incidence of this abnormality is higher than reported to date. The clinical outcome of t(7;12) patients is believed to be poor, therefore an early and accurate diagnosis is important in the clinical management and treatment. In this study, we have designed and tested a novel three-colour FISH approach that enabled us not only to confirm the presence of the t(7;12) in a number of patients studied previously, but also to identify a cryptic t(7;12) as part of a complex rearrangement. This new approach has proven to be an efficient and reliable method to be used in the diagnostic setting.
References
[1]
Keen-Kim, D.; Nooraie, F.; Raio, P.N. Cytogenetics biomarkers for human cancer. Front. Biosci. 2008, 13, 5928–5949, doi:10.2741/3127.
[2]
Lin, C.; Yang, L.; Rosenfeld, M.G. Molecular logic underlying chromosomal translocations, random or non-random? Adv. Cancer Res. 2012, 113, 241–279, doi:10.1016/B978-0-12-394280-7.00015-4.
[3]
Bohlander, S.K. Fusion genes in leukemia: An emerging network. Cytogenet. Cell Genet. 2000, 91, 52–56, doi:10.1159/000056818.
[4]
Gough, S.M.; Slape, C.I.; Aplan, P.D. NUP98 gene fusions and hematopoietic malignancies: Common themes and new biologic insights. Blood 2011, 118, 6247–6257, doi:10.1182/blood-2011-07-328880.
[5]
Marschalek, R. Mechanisms of leukemogenesis by MLL fusion proteins. Br. J. Haematol. 2011, 152, 141–154, doi:10.1111/j.1365-2141.2010.08459.x.
[6]
De Braekeleer, E.; Douet-Guilbert, N.; Morel, F.; Le Bris, M.J.; Basinko, A.; de Braekeleer, M. ETV6 fusion genes in haematological malignancies: A review. Leuk. Res. 2012, 36, 945–961, doi:10.1016/j.leukres.2012.04.010.
[7]
Simmons, H.M.; Oseth, L.; Nguyen, P.; O’Leary, M.; Conklin, K.F.; Hirsch, B. Cytogenetic and molecular heterogeneity of 7q36/12p13 rearrangements in childhood AML. Leukemia 2002, 16, 2408–2416, doi:10.1038/sj.leu.2402773.
[8]
Tosi, S.; Giudici, G.; Mosna, G.; Harbott, J.; Specchia, G.; Grosveld, G.; Privitera, E.; Kearney, L.; Biondi, A.; Cazzaniga, G. Identification of new partner chromosomes involved in fusions with the ETV6 (TEL) gene in hematologic malignancies. Genes Chromosomes Cancer 1998, 21, 223–229, doi:10.1002/(SICI)1098-2264(199803)21:3<223::AID-GCC6>3.0.CO;2-1.
[9]
Tosi, S.; Harbott, J.; Teigler-Schlegel, A.; Haas, O.A.; Pirc-Danoewinata, H.; Harrison, C.J.; Biondi, A.; Cazzaniga, G.; Kempski, H.; Scherer, S.W.; et al. t(7;12)(q36;p13), a new recurrent translocation involving ETV6 in infant leukemia. Genes Chromosomes Cancer 2000, 29, 325–332, doi:10.1002/1098-2264(2000)9999:9999<::AID-GCC1039>3.0.CO;2-9.
[10]
Tosi, S.; Hughes, J.; Scherer, S.W.; Nakabayashi, K.; Harbott, J.; Haas, O.A.; Cazzaniga, G.; Biondi, A.; Kempski, H.; Kearney, L. Heterogeneity of the 7q36 breakpoints in the t(7;12) involving ETV6 in infant leukemia. Genes Chromosomes Cancer 2003, 38, 191–200, doi:10.1002/gcc.10258.
[11]
Slater, R.M.; van Drunen, E.; Kroes, W.G.; Weghuis, D.O.; van den Berg, E.; Smit, E.M.; van der Does-van den Berg, A.; van Wering, E.; Hahlen, K.; Carroll, A.J.; et al. t(7;12)(q36;p13) and t(7;12)(q32;p13)—Translocations involving ETV6 in children 18 months of age or younger with myeloid disorders. Leukemia 2001, 15, 915–920, doi:10.1038/sj.leu.2402121.
[12]
Von Bergh, A.R.; van Drunen, E.; van Wering, E.R.; van Zutven, L.J.; Hainmann, I.; Lonnerholm, G.; Meijerink, J.P.; Pieters, R.; Beverloo, H.B. High incidence of t(7;12)(q36;p13) in infant AML but not in infant ALL, with a dismal outcome and ectopic expression of HLXB9. Genes Chromosomes Cancer 2006, 45, 731–739, doi:10.1002/gcc.20335.
[13]
Beverloo, H.B.; Panagopoulos, I.; Isaksson, M.; van Wering, E.; van Drunen, E.; de Klein, A.; Johansson, B.; Slater, R. Fusion of the homeobox gene HLXB9 and the ETV6 gene in infant acute myeloid leukemias with the t(7;12)(q36;p13). Cancer Res. 2001, 61, 5374–5377.
[14]
Ballabio, E.; Cantarella, C.D.; Federico, C.; di Mare, P.; Hall, G.; Harbott, J.; Hughes, J.; Saccone, S.; Tosi, S. Ectopic expression of the HLXB9 gene is associated with an altered nuclear position in t(7;12) leukemias. Leukemia 2009, 23, 1179–1182, doi:10.1038/leu.2009.15.
[15]
Park, J.; Kim, M.; Lim, J.; Kim, Y.; Han, K.; Lee, J.; Chung, N.G.; Cho, B.; Kim, H.K. Three-way complex translocations in infant acute myeloid leukemia with t(7;12)(q36;p13): The incidence and correlation of a HLXB9 overexpression. Cancer Genet. Cytogenet. 2009, 191, 102–105, doi:10.1016/j.cancergencyto.2009.02.007.
[16]
Hollington, P.; Neufing, P.; Kalionis, B.; Waring, P.; Bentel, J.; Wattchow, D.; Tilley, W.D. Expression and localization of homeodomain proteins DLX4, HB9, and HB24 in malignant and benign human colorectal tissues. Anticancer Res. 2004, 24, 955–962.
[17]
Wilkens, L.; Jaggi, R.; Hammer, C.; Inderbitzin, D.; Giger, O.; von Neuhoff, N. The homeobox gene HLXB9 is upregulated in a morphological subset of poorly differentiated hepatocellular carcinoma. Virchows Arch. 2011, 458, 697–708, doi:10.1007/s00428-011-1070-5.
[18]
Wildenhain, S.; Ingenhag, D.; Ruckert, C.; Degistirici, O.; Dugas, M.; Meisel, R.; Hauer, J.; Borkhardt, A. Homeobox protein HB9 binds to the prostaglandin E receptor 2 promoter and inhibits intracellular cAMP mobilization in leukemic cells. J. Biol. Chem. 2012, 287, 40703–40712.
Andreasson, P.; Hoglund, M.; Bekassy, A.N.; Garwicz, S.; Heldrup, J.; Mitelman, F.; Johansson, B. Cytogenetic and FISH studies of a single center consecutive series of 152 childhood acute lymphoblastic leukemias. Eur. J. Haematol. 2000, 65, 40–51.
[21]
Hagemeijer, A.; van Zanen, G.E.; Smit, E.M.; Hahlen, K. Bone marrow karyotypes of children with non-lymphocytic leukemia. Pediatr. Res. 1979, 13, 1247–1254, doi:10.1203/00006450-197911000-00009.
[22]
Hagemeijer, A.; Hahlen, K.; Abels, J. Cytogenetic follow-up of patients with nonlymphocytic leukemia. II. Acute nonlymphocytic leukemia. Cancer Genet. Cytogenet. 1981, 3, 109–124, doi:10.1016/0165-4608(81)90065-0.
[23]
Hauer, J.; Tosi, S.; Schuster, F.R.; Harbott, J.; Kolb, H.J.; Borkhardt, A. Graft versus leukemia effect after haploidentical HSCT in a MLL negative infant AML with HLXB9/ETV6 rearrangement. Pediatr. Blood Cancer 2008, 50, 921–923, doi:10.1002/pbc.21376.
[24]
Raimondi, S.C.; Chang, M.N.; Ravindranath, Y.; Behm, F.G.; Gresik, M.V.; Steuber, C.P.; Weinstein, H.J.; Carroll, A.J. Chromosomal abnormalities in 478 children with acute myeloid leukemia: Clinical characteristics and treatment outcome in a co-operative Pediatric Oncology Group Study POG 8821. Blood 1999, 94, 3707–3716.
[25]
Satake, N.; Maseki, N.; Nishiyama, M.; Kobayashi, H.; Sakurai, M.; Inaba, H.; Katano, N.; Horikoshi, Y.; Eguchi, H.; Miyake, M.; et al. Chromosome abnormalities and MLL rearrangements in acute myeloid leukemia of infants. Leukemia 1999, 13, 1013–1017, doi:10.1038/sj.leu.2401439.
[26]
Taketani, T.; Taki, T.; Sako, M.; Ishii, T.; Yamaguchi, S.; Hayashi, Y. MNX1-ETV6 fusion gene in an megakaryoblastic leukemia and expression of the MNX1 gene in leukemia and normal B cell lines. Cancer Genet. Cytogenet. 2008, 186, 115–119, doi:10.1016/j.cancergencyto.2008.06.009.
[27]
Wlodarska, I.; La Starza, R.; Baens, M.; Dierlamm, J.; Uyttebroeck, A.; Selleslag, D.; Francine, A.; Mecucci, C.; Hagemeijer, A.; van den Berghe, H.; et al. Fluorescence in situ hybridization characterization of new translocations involving TEL (ETV6) in a wide spectrum of hematologic malignancies. Blood 1998, 91, 1399–1406.
[28]
Vieira, L.; Marques, B.; Cavaleiro, C.; Ambrosio, A.P.; Jorge, M.; Neto, A.; Costa, J.M.; Junior, E.C.; Boavida, M.G. Molecular cytogenetic characterization of rearrangements involving 12p in leukaemia. Cancer Genet. Cytogenet. 2005, 157, 134–139, doi:10.1016/j.cancergencyto.2004.08.013.
[29]
Johansson, B.; Floretos, T.; Mitelman, F. Cytogenetic and molecular genetic evolution of chronic myeloid leukaemia. Acta Haematol. 2002, 107, 76–94, doi:10.1159/000046636.
[30]
Tosi, S.; Cabot, G.; Giudici, G.; Attuati, V.; Morandi, P.; Rambaldi, A.; Dohner, H.; Biondi, A. Detection of the breakpoint cluster region-ABL fusion in chronic myeloid leukaemia and variant Philadelphia chromosome translocations by in situ hybridisation. Cancer Genet. Cytogenet. 1996, 89, 153–156, doi:10.1016/0165-4608(96)00021-0.
[31]
Cho, S.R.; Park, S.J.; Kim, H.J.; Park, I.J.; Choi, J.R.; Jung, H.J.; Park, J.E. Acute promyelocytic leukemia with complex translocation t(5;17;15)(q35;q21;q22): Case report and review of the literature. J. Pediatr. Hematol. Oncol. 2011, 33, e326–e329.
[32]
Liu, S.; Li, Q.; Pang, W.; Bo, L.; Qin, S.; Liu, X.; Teng, Q.; Qain, L.; Wang, J. A new complex variant t(4;15;17) in acute promyelocytic leukaemia: Fluorescence in situ hybridization confirmation and literature review. Cancer Genet. Cytogenet. 2001, 130, 33–37, doi:10.1016/S0165-4608(01)00464-2.
[33]
Belloni, E.; Trubia, M.; Mancini, M.; Derme, V.; Nanni, M.; Lahortiga, I.; Riccioni, R.; Confalonieri, S.; Lo Coco, F.; di Fiore, P.P.; et al. A new complex rearrangement involving the ETV6, LOC115548, and MN1 genes in a case of acute myeloid leukaemia. Genes Chromosomes Cancer 2004, 41, 272–277, doi:10.1002/gcc.20081.
[34]
Crescenzi, B.; La Starza, R.; Nozzoli, C.; Ciolli, S.; Matteucci, C.; Romoli, S.; Rigacci, L.; Gorello, P.; Bosi, A.; Martelli, M.F.; et al. Molecular cytogenetic findings in a four-way t(1;12;5;12)(p36;p13;q33;q24) underlying the ETV6-PDGFRB fusion gene in chronic myelomonocytic leukemia. Cancer Genet. Cytogenet. 2007, 176, 67–71, doi:10.1016/j.cancergencyto.2007.03.004.
[35]
Mathew, S.; Shurtleff, S.A.; Raimondi, S.C. Novel cryptic, complex rearrangements involving ETV6-CBFA (TEL-AML1) genes identified by fluorescence in situ hybridization in pediatric patients with acute lymphoblastic leukemia. Genes Chromosomes Cancer 2001, 32, 188–193, doi:10.1002/gcc.1182.
